MaiaMilk has officially launched a shelf-stable, powdered human donor milk product designed to bring medical-grade infant nutrition – previously confined to hospital NICUs – directly to families at home. The product is the new consumer brand of Ni-Q, which has supplied donor milk to hospitals for over a decade, delivering more than four million ounces to premature and medically vulnerable infants with zero reported adverse outcomes.
Unlike formula, which uses synthetic ingredients to approximate breast milk, MaiaMilk is 100% human donor milk. The company uses proprietary freeze-drying technology to preserve breast milk’s bioactive compounds, antibodies, and nutrients while making it shelf-stable and portable. Each packet delivers standardized 20-calorie donor milk with no synthetic additives, fortifiers, or preservatives – just add warm water.
The product is manufactured in an FDA-registered facility under cGMP regulations, with comprehensive donor screening (medical history, lifestyle evaluation, blood testing), multiple testing checkpoints, and independent third-party batch verification – the same protocols used in NICU settings.
“We’ve seen how essential donor milk is for the most vulnerable infants,” said Tara Overton, Head of Operations for MaiaMilk. “But we’ve also seen the limitations of a system where access is confined to hospitals. Making donor milk shelf-stable and standardized wasn’t just a technical challenge, it was a responsibility.”
MaiaMilk is positioning itself in a gap between traditional formula and fresh donor milk – offering a product for families navigating delayed postpartum milk supply, NICU-to-home transitions, or simply looking for a feeding option backed by clinical-grade manufacturing standards without the logistics of frozen donor milk. The product requires no refrigeration until opened and is ready in seconds with no thawing.
